Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chompret

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Medical Genetics|November 1, 2005
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeG Bougeard, S Baert-Desurmont, I Tournier, et al.
Annales De Dermatologie Et De Venereologie|March 2, 2006
[Clinical and genetic study in 22 patients with basal cell nevus syndrome]C Pruvost-Balland, P Gorry, N Boutet, et al.
Familial Cancer|June 2, 2009
Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypesValérie Chaudru, M T Lo, F Lesueur, et al.
American Journal of Human Genetics|June 28, 2000
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone familiesP Ciotti, J P Struewing, M Mantelli, et al.
Journal of Medical Genetics|May 31, 2008
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS familiesG Bougeard, R Sesboüé, S Baert-Desurmont, et al.
Genes, Chromosomes & Cancer|October 2, 2001
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effectS Auroy, M F Avril, A Chompret, et al.
Lancet (London, England)|July 12, 1997
Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhoodS J Kony, F de Vathaire, A Chompret, et al.
British Journal of Cancer|June 23, 2000
P53 germline mutations in childhood cancers and cancer risk for carrier individualsA Chompret, L Brugières, M Ronsin, et al.
British Journal of Cancer|July 20, 2000
Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2E A Rapley, R Barfoot, C Bonaïti-Pellié, et al.
Journal of Medical Genetics|June 7, 2005
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanomaK Laud, C Marian, M F Avril, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Medical Genetics|November 1, 2005
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeG Bougeard, S Baert-Desurmont, I Tournier, et al.
Annales De Dermatologie Et De Venereologie|March 2, 2006
[Clinical and genetic study in 22 patients with basal cell nevus syndrome]C Pruvost-Balland, P Gorry, N Boutet, et al.
Familial Cancer|June 2, 2009
Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypesValérie Chaudru, M T Lo, F Lesueur, et al.
American Journal of Human Genetics|June 28, 2000
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone familiesP Ciotti, J P Struewing, M Mantelli, et al.
Journal of Medical Genetics|May 31, 2008
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS familiesG Bougeard, R Sesboüé, S Baert-Desurmont, et al.
Genes, Chromosomes & Cancer|October 2, 2001
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effectS Auroy, M F Avril, A Chompret, et al.
Lancet (London, England)|July 12, 1997
Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhoodS J Kony, F de Vathaire, A Chompret, et al.
British Journal of Cancer|June 23, 2000
P53 germline mutations in childhood cancers and cancer risk for carrier individualsA Chompret, L Brugières, M Ronsin, et al.
British Journal of Cancer|July 20, 2000
Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2E A Rapley, R Barfoot, C Bonaïti-Pellié, et al.
Journal of Medical Genetics|June 7, 2005
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanomaK Laud, C Marian, M F Avril, et al.
Pageof 5